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Abstract Prion diseases share a common feature in that the 
normal cellular prion .protein (PrP c) converts to a protease- 
resistant isoform PrP ~c. The c¢-helix-rich C-terminal half of 
PrP c is partly converted into []-sheet in PrP so. We have 
examined by Raman spectroscopy the structure of an octapeptide 
PHGGGWGQ that appears in the N-terminal region of PrP c 
and a longer peptide containing the octapeptide region. The 
peptides do not assume any regular structure without divalent 
metal ions, whereas Cu(II) binding to the HGGG segment 
induces formation of co-helical structure on the C-terminal side of 
the peptide chain. The N-terminal octapeptide of prion protein 
may be a novel structural motif that acts as a promoter of c~-helix 
formation. 
Key words: Prion protein; Secondary structure; 
Metal coordination; Raman spectroscopy 
1. Introduction 
The normal cellular prion protein (PrP c) is a glycolipid- 
anchored membrane-surface protein expressed in neurons 
and glial cells [1,2]. Although little is known about the func- 
tion of PrP c, recent studies suggested that PrP ('~ may play a 
role in the maintenance of cerebellar Purkinje neurons [3] and 
in sleep regulation [4]. Mature human PrP c after post-transla- 
tional modifications spans residues 23 231 of the 253 amino 
acid residues coded by a single gene [5-7]. A molecular mod- 
eling study suggested that the C-terminal half of PrP C may 
form a bundle of four ¢x-helices at residues 109 122 (HI), 
129 141 (H2), 178-191 (H3), and 202-218 (H4) [8] (Fig. 1). 
A recent NMR study on the three-dimensional structure of a 
peptide fragment (residues 121-231) of the mouse prion pro- 
tein, which lacks the N-terminal half and H1 helix region, has 
confirmed the existence of the H3 and H4 helices at the pre- 
dicted positions [9]. In the pathological process of prion dis- 
eases, PrP c is converted into a ]3-sheet-rich form of prion 
protein (prpS':), which aggregates into amyloid probably 
through intermolecular ]3-sheet formation [10]. The aggregated 
PrP sc acquires resistance to proteolytic degradation and 
causes fatal neurodegenerative diseases, including scrapie 
and bovine spongiform encephalopathy in animals and 
Creutzfeld-Jakob disease in humans [2]. Although the c~-he- 
lix-to-[3-sheet transition in the C-terminal half region may be 
related to the PrP c ~ PrP sc transformation [8,11,12], the mol- 
ecular mechanism of the conformational transition has not yet 
been clarified. 
The N-terminal region of PrP c, on the other hand, contains 
four tandem repeats of the octapeptide, Pro-His-Gly-Gly-Gly- 
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Trp-Gly-Gln (PHGGGWGQ),  at positions 60-91 with an 
analogous nonapeptide on the adjacent N-terminal side (posi- 
tions 51 59, Fig. 1). Because of its glycine- and proline-rich 
amino acid sequence, neither c~-helix nor [3-sheet structure has 
been predicted in this region [8]. The protein found in the 
PrP sc amyloid, sometimes designated PrP 27-30, lacks the 
N-terminal region due to proteolytic truncation and it is con- 
sidered that the N-terminal region is not directly related to the 
amyloid formation [13]. However, the octapeptide repeat is 
highly conserved among mammalian PrP c' proteins [14], im- 
plying some functional and structural roles of the octapeptide. 
A recent mass spectrometric study has shown that the octa- 
peptide repeat provides a binding site for divalent metal ions, 
preferentially for Cu(II) [15]. The structure of a peptide con- 
sisting of four tandem repeats of the octapeptide has been 
investigated in the presence and absence of Cu(II) by using 
circular dichroism (CD) spectroscopy [16]. Although the CD 
spectrum was affected by the metal binding, the peptide sec- 
ondary structure could not be fully revealed ue to a strong 
distortion of the spectrum by the tryptophan residues. In this 
study, we have investigated the effect of Cu(II) binding on the 
secondary structure of peptides containing the octapeptide by 
using Raman bands sensitive to the peptide conformation. 
2. Materials and methods 
Copper(II) chloride was purchased from Nacalai Tesque, Inc. The 
oligopeptides containing amino acid sequence of human prion pro- 
tein, PHGGGWGQ (NPra), HGGG, PHGGGWGQGGGTHSQ- 
WNKPS [PrP(84-103)], and three tandem repeats of NPrl, were 
synthesized on an Applied Biosystems Model 431A automated peptide 
synthesizer f om amino acid derivatives protected by the 9-fluorenyl- 
methoxycarbonyl (Fmoc) group. The peptide was purified with a 
Jasco 880 HPLC on a reversed-phase column using a 0-50% linear 
gradient of acetonitrile in 0.1% (v/v) trifluoroacetic acid. The lyophil- 
ized powder of the peptide was dissolved in 0.1 M hydrochloric acid 
and again lyophilized to remove residual trifluoroacetic acid. The pH 
of the sample solution was adjusted by addition of KOH solution. 
The concentration f the peptide was determined from UV absorption 
of tryptophan (e2s0 = 5455). Raman spectra were excited with the 
514.5-nm line (5 mW at the sample) of a Coherent Inova 70 argon 
ion laser and were recorded on a Jasco NR-1800 triple spectrometer 
equipped with a liquid-nitrogen cooled CCD detector. Frequencies of
Raman bands were reproducible to within + 0.5 cm -1. Samples were 
kept at 20°C during collection of Raman spectra. 
3. Results and discussion 
Raman spectra of H20 and D20 solutions of the NPrl 
octapeptide are shown in Fig. 2. In the absence of Cu(II), 
the peptide gives amide I (H20 solution; Fig. 2A, top) and 
amide I' (D20 solution; Fig. 2B, top) bands at 1668 and 1658 
cm 1, respectively. These amide frequencies are characteristic 
of irregular structure of the peptide main-chain [17]. The cor- 
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Fig. 1. Schematic representation f the human prion protein amino acid sequence [5-7]. The sequences of the oligopeptides, NPrl and PrP(84- 
103), are indicated at the top. 
responding amide III band,  which is expected around 1250 
cm 1 for irregular structure, may be covered by a t ryptophan 
band at 1254 cm 1 The amide II I  band exhibits a drastic 
decrease in 020  solution (Fig. 2B), reflecting the H ~ D ex- 
change of amide protons. The deuterated peptide bonds result 
in amide I I I '  bands in the 990-940 cm -1 region (not shown). 
The 1271 cm 1 band remains in the D20 solution spectrum 
and is assigned to histidine. A shoulder peak at 1237 cm -1 
(Fig. 2A) is too weak to be assigned to an amide III mode of 
]3-sheet structure and may be ascribed to t ryptophan [17]. The 
Raman spectra clearly show that the NPr l  peptide adopts an 
irregular structure in the absence of Cu(II). 
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Fig. 2. Raman spectra (175(~1180 cm -1) of H20 (A) and 020 (B) solutions of NPrl, PHGGGWGQ, at 20 mM peptide concentration and pH 
(pD) 7.4; metal-free NPrl solution (top) and Cu(II)-NPrl complex in the presence of 40 mM CuC12 (bottom), respectively. Raman scattering 
of the solvents was subtracted from the solution spectra. Assignments of Raman bands are as indicated in the panels (H, histidine; W, trypto- 
phan; amide , deprotonated main-chain amide). 
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Fig. 3. Raman spectra (1750 ll80 cm a) of H20 (A) and D.,O (B) solutions of HGGG, at 20 mM peptide concentration a d pH (pD) 7.4; 
metal-free peptide solution (top) and Cu(II)-peptide complex in the presence of 40 mM CuC12 (bottom), respectively. 
In the presence of Cu(II), the amide I and I' bands shift to 
1654 and 1649 cm 1, respectively, with significant intensity 
decreases (Fig. 2A,B; bottom). The diminution of amide I 
(I') band intensity may be ascribed to deprotonation f amide 
nitrogens induced by metal coordination. In a deprotonated 
amide group, the amide I (I') band (mainly C = O stretch) is 
replaced by two C = O/C-N stretching vibrations, i.e. an out- 
of-phase mode at ,-~ 1610 cm -1 (mainly observed in infrared 
spectra) and an in-phase mode at ~ 1420 cm 1 (strong in 
Raman spectra), owing to a significant coupling between the 
C=O and C-N stretching vibrations [18,19]. A new peak 
that appears at 1418 cm I in the D20 solution spectrum 
(Fig. 2B, bottom) is assignable to the in-phase C = O/C-N- 
stretching vibration of deprotonated amide groups. In H20 
solution, the corresponding C= O/C-N-  band is not clearly 
detected ue to the strong overlap of a tryptophan band at 
1435 cm -1 (Fig. 2A). However, the significant intensity in- 
crease at 1432 cm -1 in the presence of Cu(II) may be ascribed 
to the C=O/C-N band. 
In order to specify the metal binding site of the octapeptide, 
we have examined the Cu(II) binding properties of a fragment 
of NPq, HGGG, which is analogous to a well-known Cu(ll)- 
binding peptide, GGH, mimicking the Cu(II) transport site of 
human serum albumin [20]. As shown in the Raman spectra 
of HGGG (Fig. 3), a drastic intensity decrease of amide I (I') 
band and concomitant intensity increase at the C = O/C-N 
stretching frequency occur upon addition of Cu(II). The other 
major spectral changes observed upon binding of Cu(II) are 
associated with the metal binding to the histidine side chain. 
The 1572 cm 1 band in the spectrum of metal-free HGGG 
(Fig. 3A, top) is the histidyl Cv = C~ stretching mode that is 
sensitive to the tautomerization f imidazole ring [21]. This 
band shifts to 1590 cm -1 upon complex formation (Fig. 3A, 
bottom), suggesting that the equilibrium between N~- and NE- 
protonated tautomeric forms is altered by the metal binding 
[22]. The corresponding 1567 cm -1 band of deuterated histi- 
dine also exhibits a high frequency shift upon metal binding 
(Fig. 3B). Although histidine bands are weak compared to 
very strong tryptophan bands in the Raman spectra of 
NPq, the 1590 cm -1 peak (Fig. 2A, bottom) and the 1582 
cm -1 shoulder peak (Fig. 2B, bottom) appear in the spectrum 
of Cu(II)-NPq mixture. On the basis of these results, we 
conclude that the nitrogens of deprotonated main-chain 
amides and the imidazole side chain of the HGGG segment 
are the metal-binding sites in the Cu(II)-NPrl complex. 
As described above, main-chain amide groups involved in 
the Cu(II) coordination do not give normal amide I (I') band. 
Thus, the remaining weak amide I (I') band in the spectrum 
of Cu(II)-HGGG mixture is ascribed to a metal-unbound 
fraction of the peptide (Fig. 3). On the other hand, the re- 
maining amide I (I') band in the spectrum of Cu(II)-NPq 
mixture cannot be ascribed to Cu(II)-unbound NPq, because 
its frequency (1654 cm -1 for amide I or 1649 cm -1 for amide 
I') is significantly lower than that (1668 or 1658 cm -1) of 
metal-unbound NPra (Fig. 2). The amide I (I') frequency of 
Cu(II)-NPrl, together with the increased intensity at 1273 
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Fig. 4. Raman spectra (1750 1180 cm 1) of H20 (A) and D20 (B) solutions of PrP(84-103), PHGGGWGQGGGTHSQWNKPS, at 20 mM 
peptide concentration and pH (pD) 7.4; metal-free PrP(84-103) solution (top) and Cu(II)-PrP(84~103) complex in the presence of 60 mM 
CuCI2 (bottom), respectively. 
cm -1 (amide III, Fig. 2A), is indicative of a-helical structures 
[17]. It is very likely that the Cu(II) binding to the HGGG 
segment of NPrl promotes conformational transition of the 
adjacent peptide segment, GWGQ, from an irregular loop to 
an a-helix. 
Raman spectra of an oligopeptide composed of three suc- 
cessive copies of the octapeptide were also examined. 
Although the Cu(II) complex of the 24-mer peptide was sol- 
uble only at basic pH, the Raman spectrum at ~ pH 10 also 
revealed a-helix formation of the peptide associated with the 
metal binding to histidine side chains and deprotonated amide 
groups (data not shown). 
To address whether the c~-helical conformation i duced by 
Cu(II) binding in the octapeptide r gion affects the structure 
of adjacent peptide segment of PrP c on the C-terminal side, 
we have examined Raman spectra of a peptide, PrP(84-103), 
composed of a single octapeptide unit (residues 84-91 of 
PrP c) and the succeeding dodecapeptide (residues 92-103, 
Fig. 1). In the absence of Cu(II), PrP(84-103) gives strong 
amide I and I' bands at 1671 and 1659 cm 1, respectively, 
indicative of an irregular structure (Fig. 4A,B; top). In the 
presence of Cu(II), the 1418 cm -1 band arising from depro- 
tonated amide groups and the 1590 cm 1 band of the metal- 
bound histidine becomes prominent (Fig. 4A,B; bottom). 
Concomitant with these spectral changes, the amide I (I') 
band shifts down to the frequency region (~ 1650 cm 1) of 
c~-helical mide I (I') vibration, as in the case of NPrl. This 
apparent frequency shift of the amide I (I') band cannot be 
explained only by the a-helix formation within the octapep- 
tide unit in PrP(84-103). Another significant spectral change 
upon Cu(II) binding is observed in the frequency region of the 
main-chain skeletal C-C stretch (Fig. 5, lower two spectra). 
Both the intensity and frequency of this band are sensitive to 
the secondary structure of polypeptide [23]. A strong C-C 
stretching band appears in the 945-890 cm -1 region when 
the peptide chain forms an ct-helix, whereas a very weak or 
no band is observed for 13-sheet s ructure. Although an irreg- 
ular peptide chain also gives a C-C stretching band, the fre- 
quency of this band is generally higher than that of the ct- 
helical C-C stretching. For example, the C-C stretching band 
of poly(L-glutamic acid) exhibits a frequency shift from 926 to 
938 cm -1 upon helix-to-coil transition [24]. In the absence of 
Cu(II), PrP(84-103) gives two Raman bands in the frequency 
region; a 936 cm 1 band and a very weak band near 920 
cm -1 (Fig. 5). A drastic intensity increase of the 921 cm -1 
band, which is accompanied by an intensity decrease of the 
936 cm 1 band, occurs upon Cu(II) binding. Similar but 
slightly weaker spectral changes were also observed on metal 
binding to NPrl (Fig. 5, upper two spectra). These results, 
together with the spectral changes in the amide I (I') region, 
provide evidence that the ct-helical structure nucleated by 
Cu(II) binding in the octapeptide region extends over the 
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Fig. 5. Raman spectra (1100-800 cm -1) of H20 solutions of NPrl 
and PrP(84-103) at 20 mM peptide concentration and pH (pD) 7.4. 
From top to bottom: metal-free NPrl, NPrl in 40 mM CuCI2, 
metal-free PrP(84-103), and PrP(84-103) in 60 mM CuCI2. 
adjacent C-terminal segment of PrP(84~103). The octapeptide 
in PrP c may be a novel structural motif  that acts as a pro- 
moter of the a-helix formation. 
The peptide segment corresponding to PrP(84-103) is in 
close proximity to the putative first helix region (residues 
109 122) of a four-helix-bundle model proposed for the C- 
terminal region of PrP c [8] (see Fig. 1). Studies on peptides 
containing putative helix regions have demonstrated that the 
helix regions can take not only a-helical but also [~-sheet 
structures depending on the solution conditions [10,25,26]. A 
cooperative folding of the first and second helix regions has 
also been detected [26]. The nucleation of o~-helical structure 
induced by binding of Cu(II) in the octapeptide moti f  and the 
subsequent propagation of the a-helical structure is likely to 
contribute to the folding of the first helix and then of the 
other helices through inter-helix interactions. A possible role 
of the octapeptide motif  is to stabilize or-helical structure of 
PrP c in the presence of Cu(II). 
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